Page 2 - வளைகுடா ஒத்துழைப்பு சபை பகுதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Jun 14, 2021 DUBAI, United Arab Emirates (BUSINESS WIRE) taiba Middle East, a leading regional pharmaceutical company specializing in orphan and rare diseases in the region of Middle East/North Africa, announces that Insmed Netherlands BV, a subsidiary of Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, has granted taiba exclusive rights to market and distribute ARIKAYCE® in the Countries of Gulf Cooperation Council (Saudi Arabia, UAE, Kuwait, Oman, Qatar, Bahrain). Under the terms of the agreement, taiba will be responsible for the named patient supply program with intent to commercialize ARIKAYCE in the region following receipt of marketing authorization(s) in the territory.

United arab emiratesUnited statesUnited kingdomSaudi arabiaNeil hughesSaif al hasaniEuropean unionInsmed incorporatedCountries of gulf cooperation council saudi arabiaGulf cooperation council regionUnited arabMiddle eastNorth africaInsmed netherlandsGulf cooperation councilOrphan drug designation